Allwood Brian W, Gillespie Rencia, Galperin-Aizenberg Maya, Bateman Mary, Olckers Helena, Taborda-Barata Luis, Calligaro Gregory L, Said-Hartley Qonita, Van Zyl-Smit Richard, Cooper Christopher B, Van Rikxoort Eva, Goldin Jonathan, Beyers Nulda, Bateman Eric D
University of Cape Town Lung Institute, Cape Town, South Africa; Division of Pulmonology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
S Afr Med J. 2017 Apr 25;107(5):440-445. doi: 10.7196/SAMJ.2017.v107i5.12118.
An association between chronic airflow limitation (CAL) and a history of pulmonary tuberculosis (PTB) has been confirmed in epidemiological studies, but the mechanisms responsible for this association are unclear. It is debated whether CAL in this context should be viewed as chronic obstructive pulmonary disease (COPD) or a separate phenotype.
To compare lung physiology and high-resolution computed tomography (HRCT) findings in subjects with CAL and evidence of previous (healed) PTB with those in subjects with smoking-related COPD without evidence of previous PTB.
Subjects with CAL identified during a Burden of Obstructive Lung Disease (BOLD) study performed in South Africa were studied. Investigations included questionnaires, lung physiology (spirometry, body plethysmography and diffusing capacity) and quantitative HRCT scans to assess bronchial anatomy and the presence of emphysema (<-950 HU), gas trapping (<-860 HU) and fibrosis (>-200 HU). Findings in subjects with a past history and/or HRCT evidence of PTB were compared with those in subjects without these features.
One hundred and seven of 196 eligible subjects (54.6%) were enrolled, 104 performed physiology tests and 94 had an HRCT scan. Based on history and HRCT findings, subjects were categorised as no previous PTB (NPTB, n=31), probable previous PTB (n=33) or definite previous PTB (DPTB, n=39). Subjects with DPTB had a lower diffusing capacity (Δ=-17.7%; p=0.001) and inspiratory capacity (Δ=-21.5%; p=0.001) than NPTB subjects, and higher gas-trapping and fibrosis but not emphysema scores (Δ=+6.2% (p=0.021), +0.36% (p=0.017) and +3.5% (p=0.098), respectively).
The mechanisms of CAL associated with previous PTB appear to differ from those in the more common smoking-related COPD and warrant further study.
慢性气流受限(CAL)与肺结核(PTB)病史之间的关联已在流行病学研究中得到证实,但这种关联的机制尚不清楚。在这种情况下,CAL是否应被视为慢性阻塞性肺疾病(COPD)或一种单独的表型仍存在争议。
比较有CAL且有既往(已治愈)PTB证据的受试者与无既往PTB证据的吸烟相关COPD受试者的肺生理学和高分辨率计算机断层扫描(HRCT)结果。
对在南非进行的慢性阻塞性肺疾病负担(BOLD)研究中确定的CAL受试者进行研究。调查包括问卷调查、肺生理学(肺量计、体容积描记法和弥散功能)以及定量HRCT扫描,以评估支气管解剖结构以及肺气肿(<-950 HU)、气体潴留(<-860 HU)和纤维化(>-200 HU)的存在情况。将有PTB既往史和/或HRCT证据的受试者的结果与无这些特征的受试者的结果进行比较。
196名符合条件的受试者中有107名(54.6%)被纳入研究,104名进行了生理学测试,94名进行了HRCT扫描。根据病史和HRCT结果,受试者被分类为无既往PTB(NPTB,n = 31)、可能有既往PTB(n = 33)或确定有既往PTB(DPTB,n = 39)。与NPTB受试者相比,DPTB受试者的弥散功能较低(Δ=-17.7%;p = 0.001)和吸气量较低(Δ=-21.5%;p = 0.001),气体潴留和纤维化评分较高,但肺气肿评分无差异(分别为Δ=+6.2%(p = 0.021)、+0.36%(p = 0.017)和+3.5%(p = 0.098))。
与既往PTB相关的CAL机制似乎与更常见的吸烟相关COPD的机制不同,值得进一步研究。